Helmuth Schutz

Title: Helmuth Schutz: Innovator in Medicinal Chemistry

Introduction

Helmuth Schutz is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on purin-6-one derivatives. With a total of 4 patents to his name, Schutz has established himself as a key figure in the development of compounds for medical applications.

Latest Patents

Schutz's latest patents include the development of 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones. These compounds are synthesized by cyclizing correspondingly substituted imidazoles and derivatizing the resulting purines. The 9-substituted 2-(2-n-alkoxyphenyl)purin-6-ones are particularly valuable as active compounds in medicaments, especially for treating inflammations, thromboembolic diseases, and cardiovascular diseases. Additionally, his work on purin-6-one derivatives involves acylating appropriately substituted imidazole carboxamides and cyclizing them to yield purines. These derivatives are also suitable for use in medicaments aimed at treating cardiovascular disorders, vascular system disorders, and urogenital system issues.

Career Highlights

Helmuth Schutz is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on the development of innovative medicinal compounds that address critical health issues.

Collaborations

Throughout his career, Schutz has collaborated with esteemed colleagues such as Ulrich Niewohner and Erwin Bischoff. These collaborations have further enhanced his research and development efforts in the field of medicinal chemistry.

Conclusion

Helmuth Schutz's contributions to medicinal chemistry, particularly through his patented innovations, have had a significant impact on the development of treatments for various diseases. His work continues to influence the pharmaceutical industry and improve patient outcomes.